ModelOp Recognized in 2025 Gartner® Market Guide for AI Governance Platforms 
Market Value Lower Than Cash Assets? It’s Time to Reevaluate NIVF 
Winvest Group Announces Strategic Partnership with Greater Bay Area RWA Incubator; Southeast Asia Headquarters to Be Established in Malaysia Eve & Co Announces Results of Annual General Meeting
STRATHROY, Ontario, June 25, 2021 (GLOBE NEWSWIRE) — Eve & Co Incorporated (“Eve & Co”…
Hepion Pharmaceuticals Announces Adjournment of Annual Meeting
EDISON, N.J., June 25, 2021 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage…
Report – Erytech’s Combined Shareholders’ Meeting on June 25, 2021
    REPORT – ERYTECH’S COMBINED SHAREHOLDERS’ MEETING ON JUNE 25, 2021 SS…
Cronos Group Inc. Announces Results of 2021 Annual Meeting of Shareholders
TORONTO, June 25, 2021 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group”…
Revive Therapeutics Approved to Trade on the OTCQB Market
TORONTO, June 25, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:…
Cannabis Market Leader is Turning Customers Into Co-Owners
One of Europe’s largest CBD brands, Nordic Oil, has launched its first ever equity crowdfunding…
Saniona provides update on ongoing review of tesofensine in Mexico
PRESS RELEASE June 25, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on…
Applied Therapeutics Announces Presentation of Data on the Prevalence of Diabetic Cardiomyopathy at the 81st Scientific Sessions of the 2021 Annual Meeting of the American Diabetes Association
~1 in 5 people with diabetes or pre-diabetes have Diabetic Cardiomyopathy, a serious and progressive…
Akero Therapeutics Presents at the American Diabetes Association’s 81st Scientific Sessions, Demonstrating that Improvements in Adipose Tissue Metabolism Contributed Substantially to Improved Liver Health and Better Glycemic Control in Efruxifermin (EFX)-treated Pre-Cirrhotic NASH Patients
SOUTH SAN FRANCISCO, Calif., June 25, 2021 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic…
INVECTYS INC. TO PARTICIPATE IN THE 2021 ROTH VIRTUAL HEALTHCARE PRIVATE COMPANY FORUM ON JUNE 28TH, 2021
Houston, Texas, USA, June 25, 2021 (GLOBE NEWSWIRE) — Invectys Inc. a clinical-stage immunotherapy company…
Madrigal Pharmaceuticals Announces Presentation of Positive Clinical Data of Resmetirom from Open-Label Portion of Ongoing Phase 3 Clinical Trial MAESTRO-NAFLD-1 at The International Liver Congress™ 2021
Use of non-invasive measurements demonstrated that resmetirom: was safe and well-tolerated at 100 mg per…
Tower One Announces Closing of Definitive Agreement for Acquisition of Remaining Shares in Evotech and Settlement of Claims
VANCOUVER, British Columbia, June 25, 2021 (GLOBE NEWSWIRE) — TOWER ONE WIRELESS CORP. (CSE: TO)…
BetterLife Announces Exercise of Over-Allotment Option in Public Offering
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British…
Axiom Exhibiting at DIA 2021 Global Annual Meeting and Virtual Conference June 27- July 1, 2021
TORONTO, June 25, 2021 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), premier provider of unified…
22nd Century Group Provides Business Update from CEO Detailing Company Progress Over Past Year and Future Initiatives
BUFFALO, N.Y., June 25, 2021 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (NYSE American: XXII),…
Astellas Receives Positive CHMP Opinion for EVRENZO™ (roxadustat) for Adult Patients with Symptomatic Anemia of Chronic Kidney Disease
TOKYO, June 25, 2021 (GLOBE NEWSWIRE) — Astellas Pharma Inc. (TSE: 4503, President and CEO:Â Kenji…
LaunchPad Café Ltd. Announces Closing of Transaction with Ventana Biotech, Inc. (VNTA)
LaunchPad CafĂ© Ltd. Announces Closing of Transaction with Ventana Biotech, Inc. (VNTA) LaunchPad CafĂ© Ltd….
Y-mAbs’ 177Lu-omburtamab-DTPA for the Treatment of Patients with Medulloblastoma Receives Positive Opinion on Orphan Medicinal Product Designation by EMA
NEW YORK, June 25, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
Vir Biotechnology Presents New Clinical Data from Ongoing Trials of VIR-2218 and VIR-3434 in Patients with Chronic Hepatitis B Virus Infection at the International Liver Congress 2021
– Results demonstrate positive safety profiles and a reduction in HBsAg for two novel HBV therapies…
Veru Enrolls First Patient in Phase 3 VERACITY Clinical Trial of Sabizabulin (VERU-111) in Metastatic Castration Resistant and Androgen Receptor Targeting Agent Resistant Prostate Cancer
–Sabizabulin is a novel oral androgen receptor transport disruptor– — In Phase 1b/2 clinical study,…